attenuated vaccine


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to attenuated vaccine: inactivated vaccine

attenuated vaccine

[ə′ten·yə‚wād·əd ‚vak′sēn]
(immunology)
A suspension of weakened bacteria, viruses, or fractions thereof used to produce active immunity.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
(5) Nonlive Attenuated Vaccines Can Be Administered alongside Conventional Synthetic DMARDs and TNF[alpha]-Blocking Agents in Patients with Inflammatory Rheumatic Disease, but They Should Ideally Be Administered prior to Starting Biologics or Targeted Synthetic DMARDs Where Possible, Especially for B Cell-Depleting Therapies.
Buttery, "Recurrent 6 th nerve palsy in a child following different live attenuated vaccines: Case report," BMC Infectious Diseases, vol.
'Although the quadrivalent live attenuated vaccine remains licensed in the United States, the [Advisory Committee on Immunization Practices] did not recommend this vaccine for the 2016-2017 influenza season," the investigators wrote.
Live attenuated vaccines are prepared by sufficiently attenuating infectious organisms by passaging them in either the heterologous host system or in the cell culture.
That same year, Albert Sabin's live, attenuated vaccine, too, was licensed.
Keywords: Inclusion body hepatitis hydro pericardium syndrome; Vero cell line; Live attenuated vaccine; Cytopathogenic effect
"The live attenuated vaccine FluMist is administered intranasally (through the nose) and should be given
The intranasal, live attenuated vaccine is reserved for nonpregnant adults age [less than or equal to]49 without high-risk medical conditions and who are not in close contact with immunocompromised persons.
The live attenuated vaccine (FluMist) is considered safe if given to healthy people aged 5 to 59 years, so it would not be appropriate for the average resident of a nursing home.
Rotarix[R] is an oral, two-dose, live attenuated vaccine against rotavirus disease in infants that was licensed in 1997 by AVANT Immunotherapeutics to GSK for worldwide commercialization.
However, viremia was measured in all animals using a TaqMan PCR, irrespective of the level of the prechallenge titer, except the control group immunized with live attenuated vaccine. In fact, there was no correlation between PRNT50 titers and levels of viremia assayed by TaqMan.
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.